Prostate cancer Posts on Medivizor
Navigation Menu

Prostate cancer Posts on Medivizor

Nerve grafting to restore erectile function after radical prostatectomy

Posted by on Jun 7, 2019 in Prostate cancer | 0 comments

In a nutshell This article investigated the safety and efficacy of end-to-side nerve grafting surgery (NGS) in patients with erectile dysfunction (ED) after prostate surgery.  The authors concluded that NGS was a safe and effective treatment option for these patients. Some background Radical prostatectomy (RP) is surgery to remove the prostate....

Read More

Recovery of urinary function in elderly men vs younger men undergoing robot-assisted prostate surgery for aggressive prostate cancer

Posted by on Jun 7, 2019 in Prostate cancer | 0 comments

In a nutshell This article investigated urinary function in elderly vs younger men following robot-assisted radical prostatectomy (RARP) for aggressive prostate cancer (PC).  The authors concluded that regardless of age, there was an improvement in urinary function after the surgery.  Some background Aggressive prostate cancer is commonly...

Read More

Does diabetes increase the risk of metastases and castration resistant prostate cancer after a radical prostatectomy?

Posted by on Jun 4, 2019 in Prostate cancer | 0 comments

In a nutshell This article investigated the link between blood glucose control and long-term prostate cancer (PC) outcomes in men with diabetes mellitus (DM) who are having a radical prostatectomy (RP; complete removal of the prostate).  The authors concluded that a worse blood glucose control was associated with metastases and...

Read More

Long term outcomes of docetaxel-based chemotherapy with dexamethasone for advanced prostate cancer

Posted by on May 31, 2019 in Prostate cancer | 0 comments

In a nutshell This article investigated the safety and effectiveness of docetaxel (Taxotere)-based chemotherapy in combination with dexamethasone (Decadron) for the treatment of castration-resistant prostate cancer (CRPC). The authors concluded that this treatment combination is a safe and effective treatment option for...

Read More

Looking patients with advanced cancer to test a new immunotherapy combination

Posted by on May 31, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 1/2 trial will investigate BMS-986253, an experimental drug, in combination with nivolumab (Opdivo) to treat advanced cancer. The main outcomes will be the occurrence of side effects and tumor response. The details Advanced cancers have limited treatment options. New drugs are in development to improve patient prognosis. These...

Read More

Searching for patients with castration-resistant prostate cancer to test this new treatment option

Posted by on May 28, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial is examining the effectiveness and safety of sacituzumab govitecan (IMMU-132) in patients with metastatic castration-resistant prostate cancer (mCRPC) who are having cancer progression on abiraterone (Zytiga) or enzalutamide (Xtandi). The main outcome to be measured will be the PSA (a...

Read More

Searching for patients with prostate cancer to test low-dose or high-dose brachytherapy

Posted by on May 28, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness and safety of low dose rate (LDR) vs high dose rate (HDR) prostate brachytherapy (BT) for patients with prostate cancer (PC). The main outcome to be measured will be the quality of life in terms of urinary symptoms. This trial is recruiting in British Columbia,...

Read More

Searching for patients with metastatic prostate cancer to test this new treatment combination

Posted by on May 28, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness and safety of niraparib (Zejula) in combination with abiraterone acetate (Zytiga) and prednisone (Deltasone) vs abiraterone acetate and prednisone plus placebo for patients with metastatic prostate cancer. The main outcome to be measured will be the survival...

Read More

Looking for patients with localized prostate cancer to test stereotactic body radiotherapy after surgery

Posted by on May 19, 2019 in Prostate cancer | 0 comments

In a nutshell This phase 2 trial will investigate the safety and effectiveness of stereotactic body radiation therapy (SBRT)  in patients with localized prostate cancer (PC) who had surgical removal of the prostate. The main outcomes will be survival without recurrence and side effects. This study is recruiting in Los Angeles, California, the...

Read More